<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Lack of weight gain after angiotensin AT 1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/ Mas-dependent pathway</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-04-04">4 April 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Johanna</forename><surname>Schuchard</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Experimental and Clinical Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Lübeck</orgName>
								<address>
									<settlement>Lübeck, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">DZHK (German Centre for Cardiovascular Research)</orgName>
								<orgName type="institution">Partner Site Hamburg/Kiel/Lübeck</orgName>
								<address>
									<settlement>Lübeck, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martina</forename><surname>Winkler</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Experimental and Clinical Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Lübeck</orgName>
								<address>
									<settlement>Lübeck, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ines</forename><surname>Stölting</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Experimental and Clinical Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Lübeck</orgName>
								<address>
									<settlement>Lübeck, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Franziska</forename><surname>Schuster</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Experimental and Clinical Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Lübeck</orgName>
								<address>
									<settlement>Lübeck, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Florian</forename><forename type="middle">M</forename><surname>Vogt</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department for Radiology and Nuclear Medicine</orgName>
								<orgName type="institution">University of Lübeck</orgName>
								<address>
									<settlement>Lübeck, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jörg</forename><surname>Barkhausen</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department for Radiology and Nuclear Medicine</orgName>
								<orgName type="institution">University of Lübeck</orgName>
								<address>
									<settlement>Lübeck, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christoph</forename><surname>Thorns</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">University Clinic Schleswig-Holstein</orgName>
								<address>
									<settlement>Luebeck, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robson</forename><forename type="middle">A</forename><surname>Santos</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Institute of Biological Sciences</orgName>
								<orgName type="institution" key="instit1">National Institute of Science and Technology in Nanobiopharmaceutics</orgName>
								<orgName type="institution" key="instit2">Federal University of Minas Gerais</orgName>
								<address>
									<settlement>Belo Horizonte</settlement>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Minas Gerais</orgName>
								<address>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Bader</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Institute of Biological Sciences</orgName>
								<orgName type="institution" key="instit1">National Institute of Science and Technology in Nanobiopharmaceutics</orgName>
								<orgName type="institution" key="instit2">Federal University of Minas Gerais</orgName>
								<address>
									<settlement>Belo Horizonte</settlement>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Minas Gerais</orgName>
								<address>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Max-Delbrück-Center for Molecular Medicine (MDC)</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="laboratory">DZHK (German Centre for Cardiovascular Research)</orgName>
								<address>
									<addrLine>Partner Site Berlin</addrLine>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Center for Structural and Cell Biology in Medicine</orgName>
								<orgName type="department" key="dep2">Institute for Biology</orgName>
								<orgName type="institution">University of Lübeck</orgName>
								<address>
									<settlement>Lübeck</settlement>
									<country>Germany,</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Walter</forename><surname>Raasch</surname></persName>
							<email>walter.raasch@pharma.uni-luebeck.de</email>
							<affiliation key="aff0">
								<orgName type="department">Institute of Experimental and Clinical Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Lübeck</orgName>
								<address>
									<settlement>Lübeck, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">DZHK (German Centre for Cardiovascular Research)</orgName>
								<orgName type="institution">Partner Site Hamburg/Kiel/Lübeck</orgName>
								<address>
									<settlement>Lübeck, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department">Institute of Experimental and Clinical Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Lübeck</orgName>
								<address>
									<addrLine>Ratzeburger Allee 160</addrLine>
									<postCode>23538</postCode>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Lack of weight gain after angiotensin AT 1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/ Mas-dependent pathway</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-04-04">4 April 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">687232ADE0249E8270BCB0485106957C</idno>
					<idno type="DOI">10.1111/bph.13172</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:14+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>regulated transcript</term>
					<term>CD, cafeteria diet</term>
					<term>CRH, corticotropin-releasing hormone</term>
					<term>HPA axis, hypothalamic-pituitary-adrenal axis</term>
					<term>ITT, insulin tolerance test</term>
					<term>LRT, leptin resistance test</term>
					<term>MCH, melanin concentrating hormone</term>
					<term>NPY, neuropeptide Y</term>
					<term>OGTT, oral glucose tolerance test</term>
					<term>POMC, pro-opiomelanocortin</term>
					<term>PPO, prepro-orexin</term>
					<term>RER, respiratory exchange rate</term>
					<term>SD, Sprague-Dawley rat rats</term>
					<term>TG, transgenic</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>BACKGROUND AND PURPOSE</head><p><s>Angiotensin AT1 receptor antagonists induce weight loss; however, the mechanism underlying this phenomenon is unknown.</s><s>The Mas receptor agonist angiotensin-(1-7) is a metabolite of angiotensin I and of angiotensin II .</s><s>As an agonist of Mas receptors, angiotensin-(1-7) has beneficial cardiovascular and metabolic effects.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EXPERIMENTAL APPROACH</head><p><s>We investigated the anti-obesity effects of transgenically overexpressed angiotensin-(1-7) in rats.</s><s>We secondly examined whether weight loss due to telmisartan (8 mg•kg −1 •d −1 ) in diet-induced obese Sprague Dawley (SD) rats can be blocked when the animals were co-treated with the Mas receptor antagonist A779 (24 or 72 μg•kg −1 •d −1 ).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>KEY RESULTS</head><p><s>In contrast to wild-type controls, transgenic rats overexpressing angiotensin-(1-7) had 1.) diminished body weight when they were regularly fed with chow; 2.) were protected from developing obesity although they were fed with cafeteria diet (CD); 3.) showed a reduced energy intake that was mainly related to a lower CD intake; 5.) remained responsive to leptin despite chronic CD feeding; 6.) had a higher, strain-dependent energy expenditure, and 7.) were protected from developing insulin resistance despite CD feeding.</s><s>Telmisartan-induced weight loss in SD rats was partially antagonized after a high, but not a low dose of A779.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Different antagonists of angiotensin AT1 receptors, such as telmisartan <ref type="bibr" target="#b68">(Schupp et al., 2005;</ref><ref type="bibr" target="#b26">He et al., 2010;</ref><ref type="bibr" target="#b40">Miesel et al., 2012;</ref><ref type="bibr" target="#b42">Müller-Fielitz et al., 2012a;</ref><ref type="bibr" target="#b58">2014;</ref><ref type="bibr">2015)</ref>, candesartan <ref type="bibr" target="#b84">(Zorad et al., 2006;</ref><ref type="bibr" target="#b41">Müller-Fielitz et al., 2011;</ref><ref type="bibr">2012a)</ref> or olmesartan <ref type="bibr" target="#b76">(Vazquez-Medina et al., 2013)</ref> reduce body weight in experimental studies.</s><s>Weight loss was mostly found after high doses of AT1 receptor antagonists and was not related to a reduction in BP <ref type="bibr" target="#b41">(Müller-Fielitz et al., 2011;</ref><ref type="bibr" target="#b58">2014)</ref>.</s><s>Weight loss was also seen in patients during irbesartan therapy <ref type="bibr" target="#b33">(Kintscher et al., 2007)</ref>.</s></p><p><s>A leptin-dependent mechanism is thought to be mechanistically involved as AT1 receptor antagonists failed to reduce body weight in animals in which leptin signalling was impaired <ref type="bibr" target="#b41">(Müller-Fielitz et al., 2011)</ref>.</s><s>Furthermore, leptin sensitivity was restored by treatment with AT1 receptor antagonists <ref type="bibr" target="#b44">(Müller-Fielitz et al., 2014;</ref><ref type="bibr">2015)</ref>.</s><s>A hypothalamicpituitary-adrenal (HPA) axis-dependent mechanism seems conceivable since palatable food intake is increased to compensate for stress <ref type="bibr" target="#b14">(Dallman et al., 2004)</ref> and treatment with AT1 receptor antagonists was shown to lessen HPA activity in parallel to a reduced intake of high-calorie and palatable food <ref type="bibr" target="#b40">(Miesel et al., 2012;</ref><ref type="bibr" target="#b42">Müller-Fielitz et al., 2012a)</ref>.</s><s>In addition to these potential mechanisms, the AT1 receptor antagonist telmisartan prevented weight gain independently of food intake by activating the PPARδ-dependent pathways <ref type="bibr" target="#b26">(He et al., 2010)</ref>.</s><s>A PPARγ-related mechanism accounting for weight reduction after AT1 receptor antagonists can definitely be excluded because typical PPARγ agonists such as the thiazolidinediones tended to increase body weight, food intake, fat quantity, and adipocyte size in rats and humans <ref type="bibr" target="#b72">(de Souza et al., 2001;</ref><ref type="bibr" target="#b35">Larsen et al., 2003)</ref>.</s></p><p><s>Nevertheless, the underlying mechanisms still remain a matter of debate due to the finding that angiotensin II (AngII) itself prevented weight gain <ref type="bibr" target="#b43">(Müller-Fielitz et al., 2012b)</ref> or even to induce weight loss <ref type="bibr" target="#b12">(Cabassi et al., 2005;</ref><ref type="bibr" target="#b71">Song et al., 2005;</ref><ref type="bibr" target="#b80">Zhang et al., 2009;</ref><ref type="bibr" target="#b74">Tabony et al., 2014)</ref>.</s><s>AngII-dependent weight loss has been attributed to (i) lipolysis and thermogenesis due to its stimulation of the sympathetic outflow to adipose tissue <ref type="bibr" target="#b16">(Engeli et al., 2000;</ref><ref type="bibr" target="#b12">Cabassi et al., 2005;</ref><ref type="bibr" target="#b32">King et al., 2013)</ref>, (ii) to decreased food intake <ref type="bibr" target="#b11">(Brink et al., 1996;</ref><ref type="bibr" target="#b78">Yoshida et al., 2012)</ref> because it stimulated secretion of leptin from adipocytes <ref type="bibr" target="#b70">(Skurk et al., 2005)</ref> and to suppression of the hypothalamic expression of neuropeptide Y (NPY) and orexin <ref type="bibr" target="#b78">(Yoshida et al., 2012)</ref> and (iii) to muscle atrophy <ref type="bibr" target="#b30">(Kadoguchi et al., 2015)</ref>.</s><s>The last effect has been related to multiple mechanisms, including activation of the ubiquitin proteasome pathway, inhibition of the insulin/IGF-1/Akt/mammalian target of rapamycin axis, activation of apoptosis and mitochondrial dysfunction <ref type="bibr" target="#b71">(Song et al., 2005;</ref><ref type="bibr" target="#b80">Zhang et al., 2009;</ref><ref type="bibr" target="#b74">Tabony et al., 2014)</ref>.</s><s>The absence of AT 1 receptors in skeletal muscle and the ability of AngII to increase cytokines provide strong evidence for an indirect mechanism for muscle wasting <ref type="bibr" target="#b80">(Zhang et al., 2009)</ref>.</s><s>These tables list key protein targets and ligands in this article which are hyperlinked to corresponding entries in http:// www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY <ref type="bibr" target="#b47">(Pawson et al., 2014)</ref> and are permanently archived in the Concise Guide to PHARMACOLOGY 2013/14 ( a,b <ref type="bibr">Alexander et al., 2013a,b)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Tables of Links</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TARGETS</head><p><s>The consensual effects of AngII and AT1 receptor antagonists raise the question of whether AT1-independent mechanisms contribute to the prevention of weight gain after these antagonists, especially considering that diet-induced obesity was not observed after telmisartan in AT1 receptor-deficient mice <ref type="bibr">(Rong et al., 2010)</ref>.</s><s>We aimed in this study to investigate whether the endogenous AngII metabolite, angiotensin-(1-7) [Ang(1-7)] was involved in the prevention of weight gain following treatment with AT1 receptor antagonists.</s><s>This hypothesis is also based on observations that not only AngII <ref type="bibr" target="#b42">(Müller-Fielitz et al., 2012a;</ref><ref type="bibr" target="#b58">2014)</ref> but also Ang(1-7) is increased during AT1 receptor blockade <ref type="bibr" target="#b29">(Ishiyama et al., 2004;</ref><ref type="bibr" target="#b27">Igase et al., 2005)</ref>.</s><s>It is widely accepted that Ang(1-7) (i) is cleaved by ACE2 from AngII and/or AngI by ACE and the neutral endopeptidase <ref type="bibr" target="#b60">(Santos et al., 2012a)</ref>; (ii) has cardiovascular functions, mostly showing effects opposing those of AngII <ref type="bibr" target="#b2">(Bader, 2013;</ref><ref type="bibr" target="#b58">Santos, 2014)</ref>; and (iii) acts via the GPCR Mas <ref type="bibr" target="#b60">(Santos et al., 2012a)</ref>.</s><s>In addition to its cardiovascular effects, Ang(1-7) also beneficially affects metabolic parameters such as triglycerides and lipids <ref type="bibr" target="#b63">(Santos et al., 2010;</ref><ref type="bibr" target="#b69">Silva et al., 2013)</ref>, insulin sensitivity and glucose homeostasis <ref type="bibr" target="#b62">(Santos et al., 2008;</ref><ref type="bibr" target="#b58">2014;</ref><ref type="bibr" target="#b22">Giani et al., 2009;</ref><ref type="bibr">2012;</ref><ref type="bibr" target="#b36">Liu et al., 2012)</ref>.</s><s>In the context of Ang(1-7) regulating weight, the abdominal fat mass was increased in Mas-deficient mice <ref type="bibr" target="#b62">(Santos et al., 2008)</ref> and the captopril-induced prevention of weight gain was abolished by the Mas receptor antagonist A779 <ref type="bibr" target="#b46">(Oh et al., 2012)</ref>.</s><s>Thus, we designed our study by particularly addressing the following hypotheses: (i) the development of diet-induced obesity can be prevented by Ang(1-7) and (ii) the prevention of weight gain by AT1 receptor antagonists can at least partly be attributed to an Ang(1-7)-dependent mechanism.</s><s>To pursue our first hypothesis, we used the transgenic rat model TGR(A1-7)3292, which shows testicular-specific expression of a cytomegalovirus promoter-driven transgene, doubling the circulating levels of Ang(1-7), compared with non-transgenic control rats <ref type="bibr" target="#b59">(Santos et al., 2004)</ref>, and fed them with either standard chow or a cafeteria diet (CD).</s><s>To investigate the second hypothesis, CD-fed Sprague-Dawley (SD) rats were treated with telmisartan plus A779, while controls only received telmisartan or vehicle.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Animals</head><p><s>All animal care and experimental procedures were conducted in accordance with the NIH guidelines for the care and use of laboratory animals and approved by the animal ethics committee of the local regulatory authority.</s><s>The results of all studies involving animals are reported in accordance with the ARRIVE guidelines <ref type="bibr" target="#b31">(Kilkenny et al., 2010;</ref><ref type="bibr" target="#b38">McGrath et al., 2010)</ref>.</s><s>A total of 112 animals were used in the experiments described here.</s></p><p><s>Male TGR(A1-7)3292 rats [referred to hereafter as transgenic (TG) rats, Max Delbrück Center for Molecular Medicine, Berlin, Germany] and SD rats (Saint Berthevin, Cedex, France) were used in the experiments.</s><s>The animals were kept at room temperature with a 12 h/12 h dark (2:00 a.m.-2:00 p.m.)/light (2:00 p.m.-2:00 a.m.) cycle.</s><s>The body weights of the rats and their food and water intakes were monitored by daily weighing at 2:00 p.m. at the beginning of the light cycle.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Feeding and treatment protocols</head><p><s>Protocol 1.</s><s>At the age of 4 weeks, rats arrived in the laboratory and were kept in pairs.</s><s>After a 2 week habituation period, TG and SD rats were randomized to one of the two groups per strain.</s><s>One group of TG and SD rats (n = 11-14), respectively, was fed solely with standard chow (consisting of 6% disaccharides, 30% polysaccharides and 4% fat; Maintenance 1320, Altromin, Lage, Germany).</s><s>This feeding regimen is designated as 'control' throughout the following.</s><s>A second group of TG and SD rats (n = 11-14) had free access to standard chow plus six various commercial chocolate/ cookie bars, consisting of approximately 62% carbohydrates, 25% fat, 6% protein and 2% fibre, for the entire duration of the study (for details, see Supporting Information Table <ref type="table">S1</ref>).</s><s>The rats received only one kind of chocolate/cookie bar per day, these being switched daily in a regular manner <ref type="bibr" target="#b39">(Miesel et al., 2010)</ref>.</s><s>This feeding regimen was designated as 'CD'.</s><s>Blood samples (non-fasting) were drawn from a tail nick before and at days 36 and 71, and again at day 72 (fasting for 18 h) to determine endocrine and metabolic parameters.</s><s>Animals were phenotyped regarding BP (day 60), energy expenditure (days 64-66), insulin sensitivity [oral glucose tolerance test (OGTT) at day 72, insulin tolerance test (ITT) at day 74], leptin sensitivity (days 78-80) and fat mass (day 80).</s><s>At day 80, abdominal girth and body length were determined without knowledge of the treatments.</s><s>Body mass index (BMI) was calculated from body weight and body length (not including tail length).</s><s>At day 82, rats were killed and organs removed.</s></p><p><s>Protocol 2. To further examine age dependency, 12-week-old TG and SD rats were fed with chow or CD as described above for 160 days (n = 6 each group).</s><s>Animals were assessed only for body weight, food intake and insulin sensitivity (ITT at days 147 or 154).</s></p><p><s>Protocol 3. To address the question of whether the AT1 receptor antagonist prevented weight gain via an Ang(1-7)/ Mas-dependent pathway, one group of SD rats on CD feeding (n = 12) was treated simultaneously with telmisartan (8 mg•kg −1 •day −1 , by gavage), whereas a second group (n = 12) received in addition to telmisartan, the Mas receptor antagonist A779 via s.c.</s><s>implanted osmotic minipumps (2ML4, Alzet ® , release rate 24 μg•kg −1 •day −1 ; <ref type="bibr" target="#b43">Müller-Fielitz et al., 2012b)</ref>.</s><s>Controls (n = 12) received vehicle instead of telmisartan .</s><s>Rats that were treated with only telmisartan or vehiclereceived saline instead of A779.</s><s>All animals were monitored regarding gain in body weight, energy intake, glycaemic control (OGTT at day 24), BP (day 25), and energy expenditure (day 26-28).</s><s>At day 29, rats were killed.</s><s>Immediately after finishing protocol 3, a further group of SD rats was fed with CD and treated with 72 μg•kg −1 •day −1 A779 in addition to telmisartan to investigate possible dose effects.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Test protocols</head><p><s>The systolic BP and heart rate were determined in conscious rats <ref type="bibr" target="#b53">(Raasch et al., 2002)</ref>.</s><s>Randomized measurements were performed only between 2:00 p.m. and 5:00 p.m.</s><s>The energy expenditure, the respiratory exchange rate (RER), the drinking and feeding behaviours, and locomotion of each rat were determined within 3 days by using the PhenoMaster System ™ (TSE, Bad Homburg, Germany) but only the data from the third day were analysed <ref type="bibr" target="#b44">(Müller-Fielitz et al., 2014)</ref>.</s></p><p><s>OGTT, ITT and leptin resistance test (LRT) were performed as described previously <ref type="bibr" target="#b40">(Miesel et al., 2012;</ref><ref type="bibr" target="#b42">Müller-Fielitz et al., 2012a;</ref><ref type="bibr" target="#b58">2014)</ref>.</s><s>For additional details, see Supporting Information Appendix S1.</s><s>Fat distribution was determined in anaesthetized rats by employing the MRI technique <ref type="bibr" target="#b40">(Miesel et al., 2012;</ref><ref type="bibr" target="#b42">Müller-Fielitz et al., 2012a;</ref><ref type="bibr" target="#b58">2014)</ref>.</s><s>After preparation, the length of the femur was measured using a vernier calliper.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Biochemical analysis</head><p><s>Plasma concentrations of insulin and leptin (all from Linco, St. Charles, MO, USA) or angiotensin II (IBL, Hamburg, Germany) were determined by radioimmunoassay using commercial kits <ref type="bibr" target="#b44">(Müller-Fielitz et al., 2014)</ref>.</s><s>Blood glucose was determined using glucose sensors (Ascensia ® ELITE XL, Bayer, Leverkusen, Germany).</s><s>Triglycerides were quantified in plasma of fasting animals using a Roche/Hitachi Modular P Chemistry Analyzer <ref type="bibr">(Mannheim, Germany;</ref><ref type="bibr" target="#b44">Müller-Fielitz et al., 2014)</ref>.</s><s>Formaldehyde-fixed, paraffin-embedded sections of the liver were stained with haematoxylin and eosin according to standard protocols.</s><s>A pathologist, unaware of the treatment groups, evaluated the slides and scored each liver tissue specimen for hepatocytes with steatosis.</s></p><p><s>mRNA levels of (an-)orexigenic peptides and of AT1A/AT1B receptors, ACE2 and Mas receptors were determined in hypothalamus, liver, muscle and visceral adipose tissue by realtime quantitative PCR using SYBR Green reagent (Applied Biosystems, Weiterstadt, Germany) in an ABI Prism 7000 platform (Applied Biosystems) as previously described <ref type="bibr" target="#b54">(Raasch et al., 2004;</ref><ref type="bibr" target="#b39">Miesel et al., 2010;</ref><ref type="bibr" target="#b63">Santos et al., 2010)</ref>.</s><s>For details, see Supporting Information Appendix S1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data analysis</head><p><s>Data are expressed as means ± SEM.</s><s>As described above, rats were fed either with chow or with chow + chocolate/cookie bars.</s><s>Because of the different calorie values of chow (11.7 kJ•g −1 ) and chocolate/cookie bars (20.8 kJ•g −1 ), we calculated the energy intake (in kJ) of each rat individually to correctly assess food intake on the basis of the amounts of chow and chocolate/cookie bars consumed.</s></p><p><s>The amount of fat was semi-automatically quantified in retroperitoneal fat pads and in subcutaneous fat on the basis of the transverse T1-weighted turbo spin-echo images by using the freeware MRIcro Version 1.4 build 1 (http:// downloads.fyxm.net/MRIcro-117936.html)</s><s>and the Vitom for Windows software (Essen, Deutschland).</s><s>Only intensity signals of &gt;80 grey scale were considered to ensure that fat was being analysed.</s></p><p><s>In order to quantify the total effect for changes in plasma concentrations of glucose in response to OGTT or ITT over the observation period, the AUCs were calculated for each individual animal on the basis of the changes from baseline values.</s><s>Changes in insulin or glucose over time were similarly calculated.</s><s>The rate of fall in glucose levels (as half-life of glucose) after insulin exposure was calculated after lognormal transformation of the glucose concentrations (between 6 and 42 min after insulin injections) and by determining the slopes of linear regression lines.</s></p><p><s>Correlation coefficients (two-tailed P values) were computed according to Pearson, assuming a Gaussian distribution, with GraphPad Prism, Version 4 (GraphPad Software, Inc., La Jolla, CA, USA).</s><s>Statistical analysis was performed by one-way analysis of variance (ANOVA), followed by appropriate post hoc tests (Bonferroni or Dunnett).</s><s>Wilcoxon signed-rank test was used when Gaussian distribution differed between groups.</s><s>A two-way ANOVA, followed by Bonferroni's post hoc test for multiple comparisons, was performed to examine the effects of two variables.</s><s>Differences were considered to be statistically significant at P &lt; 0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials</head><p><s>Telmisartan: was supplied by Boehringer Ingelheim Pharmaceuticals, Inc. (Ingelheim, Germany) and A779: by Abcam plc (Cambridge, UK).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results in TG Ang(1-7)-overexpressing rats</head><p><s>Haemodynamics.</s><s>CD feeding of SD rats induced mild hypertension.</s><s>Such diet-related effects were not observed in TG rats.</s><s>Heart rate and left ventricular weight were lower in TG rats without being influenced by diet (Supporting Information Fig. <ref type="figure">S1</ref>).</s><s>AngII plasma concentrations were similar in SD and TG rats (Supporting Information Fig. <ref type="figure">S1</ref>).</s><s>CD feeding tended to increase AngII in SD rats (P = 0.065).</s></p><p><s>Weight regulation and food behaviour.</s><s>Gain in body weight was higher in young and old SD rats than in TG rats when they were fed with CD (Table <ref type="table">1</ref>, Supporting Information Fig. <ref type="figure">S2A/B</ref>).</s><s>CD feeding selectively increased growth in the girth of SD rats since BMI and fat mass, but not body and femur length were increased (Figure <ref type="figure">1A</ref>/B, Table <ref type="table">1</ref>).</s><s>CD feeding increased the number of hepatocytes with steatosis in SD, but not in TG rats (Supporting Information Fig. <ref type="figure">S3</ref>).</s><s>Energy intake was also higher in SD rats after CD than after control feeding, but less distinct in TG rats (Supporting Information Fig. <ref type="figure">S2C</ref>, Table <ref type="table">1</ref>).</s><s>Ratio between chow and chocolate/cookie bars was changed in favor of chow intake in TG, compared with SD rats (Table <ref type="table">1</ref>; Supporting Information Fig. <ref type="figure">S2D</ref>).</s><s>Water intake for the entire study duration was higher in SD than TG rats but lowered during CD feeding selectively in SD rats (Table <ref type="table">1</ref>).</s><s>In SD but not TG rats, mRNA levels of the orexigenic peptide prepro-orexin (PPO) were higher after CD feeding while levels of the anorexigenic peptide, cocaine-and amphetamine-regulated transcript (CART), were diminished.</s><s>No strain differences in (an-) orexigenic peptides were found except that levels of the Agouti related peptide (AgRP) were higher in TG rats (Supporting Information Table <ref type="table">S2 and Appendix S1</ref>).</s><s>Hypothalamic ACE2 or Mas receptor expression was not influenced either by strain or by diet (Supporting Information Fig. <ref type="figure">S4</ref>).</s><s>However, ACE2 and Mas mRNA levels were increased only in the visceral fat of TG rats.</s><s>This was not observed in other metabolic tissues.</s><s>Mas expression decreased in SD but not TG rats, when fed with CD (Supporting Information Fig. <ref type="figure">S5</ref>).</s></p><p><s>Leptin sensitivity.</s><s>Plasma leptin was selectively increased in SD rats when fed with CD (Figure <ref type="figure">1C</ref>).</s><s>The positive correlation between plasma leptin and food intake suggests that leptin resistance developed in CD-fed SD rats.</s><s>In TG rats, however, energy intake was not positively associated with food intake after CD feeding or indeed negatively associated after control feeding, indicating leptin sensitivity (Figure <ref type="figure">1D</ref>).</s><s>The effects of Ang(1-7) on leptin sensitivity were further investigated by performing LRTs.</s><s>Following leptin injections, energy intake was selectively enhanced in SD rats in response to CD, compared with control feeding; this change was not observed in TG rats (Figure <ref type="figure">2A/B</ref>).</s><s>Furthermore, body weight was reduced upon leptin injections in all groups except for Table <ref type="table">1</ref> Growth in SD and TG rats after long-term feeding with high-calorie cafeteria diet (CD) Data shown are means ± SEM, n = 9-14.</s><s>*P &lt; 0.05, significantly different from corresponding control rats, fed standard chow.</s><s>† P &lt; 0.05, significant differences between SD and TG rats.</s><s>‡ P &lt; 0.05, significant differences between SDCD and TGCD.</s><s>CD-fed SD rats (Figure <ref type="figure">2C</ref>/D), confirming that leptin sensitivity was preserved in TG rats, in spite of CD feeding.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SDcontrol</head><p><s>Energy expenditure.</s><s>Energy expenditure of TG rats tended to be increased after control feeding (Figure <ref type="figure">3A</ref>) or was increased after CD feeding (Figure <ref type="figure">3B</ref>) compared with appropriate SD controls.</s><s>Strain differences in energy expenditure were more pronounced during light than during dark periods and were only influenced to a minor degree by diet (Figure <ref type="figure">3C/D</ref>).</s><s>Respiratory index was lower in CD-fed TG than in CD-fed SD rats, which also was more evident during light than during dark periods (Figure <ref type="figure">3E-H</ref>).</s><s>No strain and diet differences were observed in locomotion except that locomotion was increased in SD rats after CD feeding during the dark period (Figure <ref type="figure">3I-L</ref>).</s><s>Energy intake (particularly during the dark phase) was also higher in SD rats than in TG rats in calorimetric experiments (Figure <ref type="figure">3M-P</ref>).</s></p><p><s>Glucose control.</s><s>Fasting glucose and insulin levels were indeed lower in younger TG rats than in SD controls when only fed with chow (Figure <ref type="figure">4A/D</ref>).</s><s>However, we did not detect any strain differences regarding insulin sensitivity in lean animals by OGTT or ITT (Figures <ref type="figure">4 and 5</ref> and Supporting Information Fig. <ref type="figure">S6</ref>).</s><s>CD feeding impaired glucose utilization selectively in SD rats as (i) baseline insulin (Figure <ref type="figure">4D</ref>) was doubled, (ii) glucose (Figure <ref type="figure">4B and C</ref>) and insulin responses (Figure <ref type="figure">4E</ref> and F) in OGTT were clearly increased in SD but not in TG rats, and (iii) the glucose response was attenuated upon insulin challenge in ITT.</s><s>Half-life of glucose decline and maximal glucose reduction were selectively lower in SD rats and the AUC was increased (Figure <ref type="figure">5</ref>).</s><s>This pattern of reaction could also be seen in the older animals (Supporting Information Fig. <ref type="figure">S6</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results of treating SD rats with telmisartan + A779</head><p><s>Haemodynamics.</s><s>Vehicle + saline-treated controls were hypertensive and BP was normalized by telmisartan but not further influenced by A779 (Supporting Information Fig. <ref type="figure">S7A</ref>).</s><s>Heart rate did not differ between groups (Supporting Information Fig. <ref type="figure">S7B</ref>).</s><s>Left ventricular weight was reduced with respect to BP reduction (Supporting Information Fig. <ref type="figure">S7C</ref>).</s><s>AngII plasma levels markedly increased after telmisartan while A779 co-treatment had no further effect (Supporting Information Fig. <ref type="figure">S7D</ref>).</s></p><p><s>Weight regulation and food behaviour.</s><s>Gain in body weight was lessened by 4 weeks of treatment with telmisartan.</s><s>The anti-obesity effects of telmisartan were partly reduced when SD rats additionally received 24 μg•kg −1 •day −1 (31%, ns) or Leptin sensitivity is impaired in SD rats after CD feeding, but preserved in TG rats.</s><s>CD feeding induces leptin resistance in SD rats, which is selectively prevented in TG rats.</s><s>At the 1st day, leptin was injected at 8:00 a.m., 11:00 a.m., 2:00 p. 72 μg•kg −1 •day −1 A779 (60%, P &lt; 0.05; Figure <ref type="figure">6A</ref>).</s><s>Weights of livers and kidneys were not affected by A779 co-treatment.</s><s>Energy expenditure, in terms of locomotion (Supporting Information Figure <ref type="figure">S8G</ref>-I), were slightly increased by telmisartan, compared with controls during the light period, but not during the dark period, while A779 co-treatment had no further effect on these parameters.</s><s>RER was not altered by any treatment regimen (Supporting Information Fig. <ref type="figure">S8D-F</ref>).</s></p><p><s>The energy intake of rats receiving 72 μg•kg −1 •day −1 A779 was higher (especially during the dark period) than that of other groups (approximately 20%; Supporting Information Fig. <ref type="figure">S8K-M</ref>).</s><s>The proportion of palatable CD intake on total energy intake of controls was 77 ± 2% and was not influenced by any treatment regimen.</s><s>Total water intake of vehicle +</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 3</head><p><s>Energy expenditure (EE; A-D), respiratory ratio (RER, E-H), locomotion (I-L) and energy intake during indirect calorimetry measurements.</s><s>Animals were housed for 3 days in calorimetry cages, but only the data from the third day are shown.</s><s>The time-dependent comparison between SD and TG rats is shown in terms of feeding; control in A, E, I, M and CD in B, F, J, N. Mean values during light and dark periods were calculated for EE (C, D), RER (G, H), and locomotion (K, L), whereas total energy intake is shown separately for the light (O) and dark (P) periods.</s><s>Means ± SEM, n = 11-14, *P &lt; 0.05 significantly different from appropriate control-fed rats.</s></p><p><s>saline-treated rats was 705 ± 27 mL and was not influenced by any treatment.</s><s>Levels of the orexigenic peptides AgRP and NPY as well as the anorexigenic peptide CART were higher in telmisartan-treated rats than in controls (Supporting Information Table <ref type="table">S3</ref> and Appendix S1).</s><s>When telmisartan-treated rats additionally received 72 μg•kg −1 •day −1 A779, levels of mRNA for melanin concentrating hormone (MCH) and PPO were increased in the hypothalami of these rats, which corresponds to the higher energy intake found in these animals (Supporting Information Table <ref type="table">S3</ref>).</s><s>Hypothalamic mRNA levels of ACE2, Mas, and AT1A/AT1B receptors were not influenced either by telmisartan or by A779 co-treatment (Supporting Information Fig. <ref type="figure">S5</ref>).</s><s>Moreover, neither telmisartan treatment nor co-treatment with A779 modified Mas mRNA levels in metabolic tissues (Supporting Information Fig. <ref type="figure">S6</ref>).</s></p><p><s>Glucose control.</s><s>Baseline fasting glucose and glucose response in OGTT were similar between groups (Figure <ref type="figure">7A-C</ref>).</s><s>However, telmisartan improved glucose utilization as the insulin response to glucose challenge was decreased, compared with controls.</s><s>A dose of 72 μg•kg −1 •day −1 A779 increased the insulin response in OGTT (Figure <ref type="figure">7D-F</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TG, but not SD rats, were protected from developing obesity</head><p><s>Body weight of control-fed TG rats was lower than that of SD rats, being associated with a lower energy intake but higher energy expenditure.</s><s>SD rats became leptin and insulin resistant, hypophagic, obese and hypertensive when they were fed with CD <ref type="bibr" target="#b45">(Müller-Fielitz et al., 2015)</ref> while none of these adverse effects was seen in TG rats although they were also fed with CD, confirming the anti-obesity effects of Ang(1-7) already seen previously <ref type="bibr" target="#b62">(Santos et al., 2008;</ref><ref type="bibr">2012b;</ref><ref type="bibr" target="#b2">2013)</ref>.</s><s>CD feeding impaired glucose utilization in SD rats, but not in TG rats.</s><s>(A) baseline glucose levels, (B) plasma glucose levels in response to an oral glucose tolerance test (1 g glucose•kgbw −1 ), (C) AUC of plasma glucose time curves.</s><s>(D) Baseline insulin levels; (E) plasma insulin levels in OGTT, (F) AUC of plasma insulin time curves.</s><s>Means ± SEM, n = 11-14, *P &lt; 0.05, significantly different from control.</s></p><p><s>It seems rather unlikely that enhanced diuresis participates in the reduced weight gain since even water excretion was increased by Ang(1-7) <ref type="bibr" target="#b25">(Handa et al., 1996)</ref> and urinary volume was decreased in Mas-deficient mice <ref type="bibr" target="#b51">(Pinheiro et al., 2009)</ref>.</s><s>Here, we showed that the water intake of TG rats tended to decrease rather than increase, thus not supporting the involvement of diuresis, which nonetheless would induce only a short-lasting effect on body weight.</s></p><p><s>In contrast to the findings of others showing that Mas protein increased in obese rats <ref type="bibr" target="#b57">(Rubio-Ruiz et al., 2014)</ref>, we showed here that Mas mRNA levels were doubled in the adipose tissue of TG rats.</s><s>It is possible that this increase might lower the fat mass of TG rats by increasing lipolysis as Ang(1-7) increased glycerol release from adipocytes in a Masdependent manner <ref type="bibr" target="#b46">(Oh et al., 2012)</ref>.</s><s>Here, we observed that RER was lower in TG rats after CD feeding, which indicates a higher degree of fat burning and lipolysis.</s><s>In addition to this direct effect, we could speculate that lipolysis may also be indirectly enhanced in response to Ang(1-7) by stimulating the sympathetic outflow as observed for AngII <ref type="bibr" target="#b32">(King et al., 2013)</ref> since Ang(1-7) stimulates peripheral noradrenergic neurotransmission <ref type="bibr" target="#b24">(Gironacci et al., 2013)</ref>.</s></p><p><s>It is interesting that during CD feeding the energy intake actually increased in both strains but TG rats did not become obese as energy expenditure was coincidently higher.</s><s>Regarding feeding behaviour, TG rats seemed to prefer standard chow to the CD, compared with SD rats, giving rise to speculation as to whether Ang(1-7) affects reward.</s><s>Food preference for chow was also found in telmisartan-treated rats and, in the context of reward, to depend on diminished dopamine signalling <ref type="bibr" target="#b45">(Müller-Fielitz et al., 2015)</ref>.</s><s>In contrast, Ang(1-7) increases dopamine release <ref type="bibr" target="#b73">(Stragier et al., 2005)</ref>, making this pathway rather unlikely to account for the food preference of TG rats.</s><s>Reward was also shown to be associated with lower HPA axis activity <ref type="bibr" target="#b13">(Corwin et al., 2011)</ref> and Ang(1-7) diminished HPA activity <ref type="bibr" target="#b82">(Zhu et al., 2014)</ref>, thus contributing to the observed food preference.</s><s>Supporting this concept, intake of palatable food was increased by stress <ref type="bibr" target="#b48">(Pecoraro et al., 2004)</ref> but reduced by telmisartan when stress reactions were also lessened <ref type="bibr" target="#b40">(Miesel et al., 2012)</ref>.</s></p><p><s>Within the last few decades, a firm link has been established between obesity and low-grade inflammation in peripheral tissues but also in the hypothalamus.</s><s>Obesityinduced inflammation prompts the CNS to increase food intake and reduce energy expenditure, thus supplying more nutrients to an expanding adipose tissue <ref type="bibr" target="#b50">(Pimentel et al., 2014)</ref>.</s><s>Ang(1-7) protects white adipose tissue from the proinflammatory state stimulated by a high-fat diet, thus contributing to the anti-obesity effects of this peptide <ref type="bibr" target="#b65">(Santos et al., 2012b)</ref>.</s><s>Inflammation disrupts leptin signalling pathways <ref type="bibr" target="#b50">(Pimentel et al., 2014)</ref>.</s><s>Here, we did not determine any cytokine levels in our groups of rats.</s><s>Nevertheless, we did investigate whether leptin sensitivity was modified in TG rats as we have demonstrated here and elsewhere that triglycerides are increased in SD rats after CD feeding <ref type="bibr" target="#b45">(Müller-Fielitz et al., 2015)</ref> while triglyceride levels of TG rats were per se lower and not affected by CD feeding.</s><s>Accordingly, triglycerides were increased in Mas-deficient mice <ref type="bibr" target="#b69">(Silva et al., 2013)</ref>.</s><s>Insulin response is impaired by CD feeding in SD, but not in TG rats.</s><s>(A) Glucose plasma concentrations after insulin injections (0.6 IU insulin•kgbw −1 , s.c.).</s><s>The maximal glucose decrease was lower (C) and both the half-life (B) and the AUC (D) were higher in SDCD than in SDcontrol, indicating impaired glucose utilization.</s><s>Strain differences could be observed for all parameters.</s><s>Means ± SEM, n = 11-14, *P &lt; 0.05, significantly different from SDcontrol.</s></p><p><s>High serum triglycerides impair the ability of the blood-brain barrier (BBB) to transport leptin <ref type="bibr" target="#b5">(Banks et al., 2004)</ref>.</s><s>Chronic CD feeding induced leptin resistance <ref type="bibr" target="#b45">(Müller-Fielitz et al., 2015)</ref>, which also occurred in the SD rats in our study as (i) the total energy intake exceeded that of control-fed animals despite higher plasma leptin levels, (ii) plasma leptin positively correlated with energy intake and (iii) energy intake in response to exogenous leptin was higher.</s><s>In contrast, diet did not affect baseline plasma leptin in TG rats, and TG rats also showed intact leptin function during CD feeding.</s><s>We assume that leptin transport across the BBB is impaired in SD rats but still intact in TG rats as impaired transport of leptin across the BBB via a saturable leptin transporter is likely to represent a major component of the peripheral leptin resistance <ref type="bibr" target="#b4">(Banks et al., 1999;</ref><ref type="bibr" target="#b3">Banks and Farrell, 2003)</ref>.</s></p><p><s>TG, but not SD rats, were protected from developing insulin resistance</s></p><p><s>In agreement with others, we found better glucose control in TG than SD rats receiving the high-calorie diet <ref type="bibr" target="#b65">(Santos et al., 2012b;</ref><ref type="bibr" target="#b2">2013)</ref>, which may be related to the following mechanisms.</s></p><p><s>Ang(1-7) improved cellular glucose uptake in vitro <ref type="bibr" target="#b69">(Silva et al., 2013;</ref><ref type="bibr" target="#b67">Santos et al., 2014)</ref>, it also affected insulin signalling by stimulating the phosphorylation of JAK2 and insulin receptor substrate-1 <ref type="bibr" target="#b21">(Giani et al., 2007)</ref> and ameliorated the inhibitory effect of AngII on glucose transport activity <ref type="bibr" target="#b52">(Prasannarong et al., 2012)</ref>.</s></p><p><s>Using different diabetic animal models, the beneficial effects of Ang(1-7) on glucose utilization were confirmed as (i) glycaemic control was better in diabetic db/db mice when they were infected with an adenovirus expressing human ACE2 <ref type="bibr" target="#b7">(Bindom et al., 2010)</ref>; (ii) pancreatic microcirculation and intra-islet microvessel density were improved <ref type="bibr" target="#b79">(Yuan et al., 2013)</ref>; (iii) short-term Ang(1-7) infusions improved insulin resistance in fructose-fed rats and attenuated diabetic nephropathy in Zucker diabetic fatty rats <ref type="bibr" target="#b22">(Giani et al., 2009;</ref><ref type="bibr">2012)</ref>; (iv) an oral Ang(1-7) formulation reversed hyperglycaemia in transgenic rats with inducible insulin resistance <ref type="bibr" target="#b67">(Santos et al., 2014);</ref><ref type="bibr">and (v)</ref> Ang(1-7) improved the effect of insulin by recruiting muscle microvasculature <ref type="bibr" target="#b19">(Fu et al., 2014)</ref>.</s><s>In line with these Ang(1-7) effects, Mas gene-deleted mice presented with glucose intolerance and reduced insulin sensitivity as well as a decrease in insulin-stimulated glucose uptake by adipocytes and decreased GLUT4 in adipose tissue <ref type="bibr" target="#b62">(Santos et al., 2008)</ref>.</s></p><p><s>Ang(1-7) improves glucose control in obesity.</s><s>As expected, CD feeding of SD rats induced insulin resistance, which may be partly attributed to a hepatic mechanism because nonalcoholic steatohepatitis, a typical outcome of obesity, is strongly associated with hepatic insulin resistance and type 2 diabetes <ref type="bibr" target="#b9">(Birkenfeld and Shulman, 2014)</ref> and, in our study, we found that SD rats fed solely with CD developed steatosis.</s><s>None of these problems was observed in TG rats despite CD feeding.</s><s>Accordingly, glucose control was improved, obesity was prevented and hepatic inflammation was reduced in rats receiving a high-fat diet and simultaneously being orally treated with Ang(1-7) <ref type="bibr" target="#b17">(Feltenberger et al., 2013;</ref><ref type="bibr" target="#b66">Santos et al., 2013)</ref>.</s><s>In obesity, the intramyocellular triglyceride content contributes to aggravating insulin resistance <ref type="bibr" target="#b75">(Turner et al., 2014)</ref>.</s><s>Higher triglyceride plasma levels in CD-fed SD rats but strain-dependent lower levels confirm this notion in our study.</s><s>At least, inflammation has been proposed as a critical factor causing insulin resistance.</s><s>In this regard, the antiinflammatory potency of Ang(1-7) may also contribute to the improved glucose control <ref type="bibr" target="#b65">(Santos et al., 2012b)</ref>.</s><s>Ang(1-7) may also improve glucose control by regulating energy intake and expenditure.</s><s>It may be assumed that enhanced energy expenditure during the light period is functionally important for alterations in glucose metabolism in TG rats when the light period is interpreted as a sedentary state.</s><s>It is well known that insulin sensitivity is impaired in sedentary conditions but can be restored as a result of physical activity <ref type="bibr" target="#b15">(Duvivier et al., 2013)</ref>.</s><s>However, our study gave no evidence of increased physical activity in TG rats in terms of locomotion.</s><s>Moreover, energy expenditure tended to be higher during the dark period and RER was lower in TG rats during the night, indicating better fat burning.</s><s>To better investigate the relation between physical activity and energy balance, additional experiments should be performed by using a combined setting of treadmills and indirect calorimetry.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Telmisartan (partly) prevents weight gain via an Ang(1-7)/Mas-dependent mechanism</head><p><s>According to our previous findings in diet-induced rat obesity, telmisartan prevented weight gain <ref type="bibr" target="#b40">(Miesel et al., 2012;</ref><ref type="bibr" target="#b42">Müller-Fielitz et al., 2012a;</ref><ref type="bibr" target="#b58">2014)</ref>.</s><s>A779 did not affect weight regulation when a dose of 24 μg•kg −1 •day −1 was administered.</s><s>However, treatment with a threefold higher A779 dose of A779 partly reversed the telmisartan-induced prevention of weight gain.</s><s>This finding provides evidence that prevention of weight gain by AT1 receptor antagonists is partly mediated by an Ang(1-7)-dependent mechanism.</s><s>Captopril also prevented weight gain in lean SD rats while Ang(1-7) was elevated and A779 (24 μg•kg −1 •day −1 ) was demonstrated to antagonize captopril's effect on weight regulation <ref type="bibr" target="#b46">(Oh et al., 2012)</ref>.</s><s>In another report, captopril failed to reduce body weight but increased plasma and tissue Ang(1-7) <ref type="bibr" target="#b6">(Benter et al., 2011)</ref>.</s><s>In fact, we previously observed a reduction in weight gain in lean rats after captopril, but not after ramipril, enalapril or fosinopril, raising the question of whether these effects of captopril on body weight were related to ACE inhi- bition <ref type="bibr" target="#b53">(Raasch et al., 2002)</ref>.</s><s>Nonetheless, the anti-obesity effects of ACE inhibitors seem to be minor compared with those of AT1 receptor antagonists under equieffective antihypertensive dosing <ref type="bibr" target="#b40">(Miesel et al., 2012)</ref>.</s><s>Plasma Ang(1-7) is known to be increased in rats both after ACE inhibition <ref type="bibr" target="#b6">(Benter et al., 2011;</ref><ref type="bibr" target="#b46">Oh et al., 2012)</ref> and after AT1 receptor blockade <ref type="bibr" target="#b29">(Ishiyama et al., 2004;</ref><ref type="bibr" target="#b27">Igase et al., 2005)</ref> and was associated with a reduction in body weight.</s><s>An increase in Ang(1-7) in the presence of AT1 receptor antagonists depends on more locally available AngII as renin is up-regulated in the circulation.</s><s>The elevated levels of plasma Ang(1-7) observed following ACE inhibition are due to the fact that ACE is responsible for the breakdown of Ang(1-7) <ref type="bibr" target="#b77">(Yamada et al., 1998;</ref><ref type="bibr" target="#b18">Ferrario et al., 2005)</ref>.</s><s>It is surprising that Ang(1-7) plasma levels normalize after captopril plus A779 <ref type="bibr" target="#b46">(Oh et al., 2012)</ref> because (i) A779 blocks Ang(1-7) effects at Mas receptors and does not influence Ang(1-7) biosynthesis, and (ii) despite simultaneous Mas receptor blockade, captopril should block the degradation of AngII to Ang(1-7) via ACE.</s><s>Circulating Ang(1-7) levels were not determined in our study as this peptide exerts its effects on the receptors at the local tissue level.</s><s>There, ACE2 is expressed and metabolizes AngII to Ang(1-7), which is very short-lived and scarcely reaches the bloodstream before being degraded.</s><s>An up-regulation of ACE2 and Mas receptors in the visceral fat of TG rats, as seen here may support the importance of local Ang(1-7) for its biological effects.</s><s>Nevertheless, we cannot exclude the possibility that telmisartan exerts its effects via the Ang(1-7) receptor Mas or its downstream signalling pathways in this part of the study.</s></p><p><s>BP and glucose homeostasis were analysed as secondary parameters.</s><s>BP was reduced by telmisartan but not further altered by administering A779 at the same time.</s><s>In contrast, a captopril-induced BP reduction was related to Ang(1-7) <ref type="bibr" target="#b6">(Benter et al., 2011)</ref> and seems to reflect the vasodilator effects of Ang(1-7) <ref type="bibr" target="#b2">(Bader, 2013)</ref>.</s><s>However, the hydralazineinduced drop in BP was also antagonized by A779 although Ang(1-7) was normal, which might indicate a non-specificity due to 10-fold higher A779 dose (744 μg•kg −1 •day − , i.p.) as used by <ref type="bibr" target="#b6">Benter et al. (2011)</ref>.</s><s>Moreover, Ang(1-7)-induced vasodilatation need not necessarily be attributed to Mas receptors, as in younger rats (similar to those used in this study), the vasodepressor effects of Ang(1-7) were attributed to an AT2 receptor-dependent mechanism and only in older rats, were related to stimulation of Mas receptors <ref type="bibr" target="#b10">(Bosnyak et al., 2012)</ref>.</s></p><p><s>As has repeatedly been shown, insulin response to OGTT was lessened by telmisartan, indicating improved insulin sensitivity <ref type="bibr" target="#b40">(Miesel et al., 2012;</ref><ref type="bibr" target="#b42">Müller-Fielitz et al., 2012a;</ref><ref type="bibr" target="#b58">2014)</ref>.</s><s>It is supposed that reduced insulin response in OGTT after telmisartan may be attributed to an Ang(1-7)-dependent mechanism because the insulin secretion after telmisar-tan+72 μg A779 exceeded control levels.</s><s>This assumption is strengthened by observations showing that insulin was reduced in transgenic animals with high Ang(1-7) (Figure <ref type="figure">4</ref>) and in fructose-fed rats after Ang(1-7) administration <ref type="bibr" target="#b22">(Giani et al., 2009)</ref>.</s></p><p><s>In summary, we clearly show here that Ang(1-7) lowers diet-induced obesity in rats and that the anti-obesity effects of telmisartan can partly be attributed to an Ang(1-7) mechanism.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Figure 1Fat mass and plasma leptin are enhanced by CD feeding in SD, but not in TG rats (protocol 1).</s><s>(A) Typical MRI images obtained by transverse T1-weighted turbo spin-echo MRI.</s><s>(B) The abundance of visceral and subcutaneous fat deposits was quantified by computer-assisted planimetry.</s><s>(C) Plasma levels of leptin at the end of the study; (D) Correlation between plasma leptin and energy intake.</s><s>Means ± SEM, n = 9-14, *P &lt; 0.05, significantly different from control or as indicated.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>Figure 2</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s>m. and 5:00 p.m. (100 μg•kgbw −1 s.c. each time) and at 8:00 p.m. (200 μg•kgbw −1 s.c.).</s><s>At the second day, rats were treated with leptin at 8:00 and 11:00 a.m.</s><s>(100 μg•kgbw −1 s.c.) and at 2:00 p.m. (200 μg•kgbw −1 s.c.).</s><s>The grey bars indicate the dark periods.</s><s>(A/B) The energy intake after exogenous leptin is increased in CDcompared with chow-fed control SD, which indicates leptin resistance, but remained unaffected in TG rats.</s><s>(C/D) The reduction in body weight after exogenous leptin is lessened in CD-compared with control-fed SD rats, but remained unaffected in TG rats.</s><s>Means ± SEM, n = 11-14, *P &lt; 0.05, significantly different from control .</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc><div><p><s>Figure 4</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head></head><label></label><figDesc><div><p><s>Figure 5</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc><div><p><s>Figure 6Regulation of growth in telmisartan (TEL) -treated animals in the presence or absence of the Mas receptor antagonist A779 (24 or 72 μg•kg −1 •day −1 ); (B) liver weight; (C) kidney weight.</s><s>Means + SEM, n = 11-12; P &lt; 0.05, significantly different from vehicle + saline.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head></head><label></label><figDesc><div><p><s>Figure 7Effects of telmisartan (TEL) and telmisartan+A779 on glucose (A-C) and insulin levels (D-F) of CD-fed SD rats in response to an OGTT.</s><s>(A/D) Baseline levels of fasting glucose and insulin, (B/E) plasma glucose and insulin levels in response to glucose challenge (1 g glucose•kgbw −1 ).</s><s>(C/F) AUCs of glucose and insulin of concerning plasma concentration time curves; Means ± SEM, n = 12, *P &lt; 0.05, significantly different from vehicle + saline.</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Ang(1-7) and weight loss after AT1 blockade British Journal of Pharmacology (2015) 172 3764-3778 3767</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Ang(1-7) and weight loss after AT1 blockade British Journal of Pharmacology (2015) 172 3764-3778 3769</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">British Journal ofPharmacology (2015) 172 3764-3778 3771</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Ang(1-7) and weight loss after AT1 blockade British Journal of Pharmacology (2015) 172 3764-3778 3773</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Ang(1-7) and weight loss after AT1 blockade British Journal of Pharmacology (2015) 172 3764-3778 3775</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Ang(1-7) and weight loss after AT1 blockade British Journal of Pharmacology (2015) 172 3764-3778 3777</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>This study was supported by the Excellent Funding of the Medical Section of the University of Lübeck and by funding from the German Center for Cardiovascular Research (Grant Number 81X2700101) and the Deutsche Forschungsgemeinschaft DFG (GRK 1957).</s><s>Walter Raasch received telmisartan from Boehringer Ingelheim Pharmaceuticals, Inc. (Ingelheim, Germany).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head><p><s>J. S., M. W., I. S., F. S., F. M. V., J. B., C. T., M. B. and W. R. performed the research; W. R., M. B. and R. A. S. designed the research study; W. R. and J. S. analysed the data; and W. R., J. S., R. A. S. and M. B. wrote the paper.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p><s>No conflict of interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting information</head><p><s>Additional Supporting Information may be found in the online version of this article at the publisher's web-site: http://dx.doi.org/10.1111/bph.13172</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure S3</head><p><s>Histological findings of livers from control-or CD-fed SD and TG rats.</s><s>Means ± SEM, n = 11-14.</s><s>*P &lt; 0.05 versus control.</s><s>Tissue specimens were evaluated, without knowledge of treatments, based on and scored for hepatocytes with steatosis.</s><s>Figure <ref type="figure">S4</ref> mRNA levels of components of the ACE2, Mas, and AT1A and AT1b receptors in hypothalami of rats of protocol 2 (control-or CD-fed SD and TG rats) and protocol 3, respectively [CD-fed SD rats that were treated with telmisartan (TEL; 8 mg•kg −1 •day −1 ) or telmisartan plus A779 (24 or 72 μg•kg −1 •day −1 ) while controls received vehicle + saline].</s><s>Means ± SEM. Figure <ref type="figure">S5</ref> mRNA levels of MAS and ACE2 in different metabolic tissues of rats of protocol 2 (control-or CD-fed SD and TG rats) and protocol 3, respectively [CD-fed SD rats that were treated with telmisartan (TEL; 8 mg•kg −1 •day −1 ) or telmisartan plus A779 (24 or 72 μg•kg −1 •day −1 ) while controls received vehicle + saline].</s><s>Means ± SEM. Figure <ref type="figure">S6</ref> Insulin response is impaired by CD feeding in SD but not in TG rats (protocol 2).</s><s>(A) Fasting glucose levels; (B) glucose plasma concentrations after insulin injections (0.6 IU insulin•kgbw −1 , s.c.).</s><s>The AUC (C), the minimal glucose levels (D), the time points of minimal glucose levels (E) and the half-life of glucose decline (F) were higher in SDCD than in SDcontrol, indicating impaired glucose control.</s><s>A strain difference could be observed for all parameters.</s><s>Means ± SEM, n = 11-14, *P &lt; 0.05. Figure <ref type="figure">S7</ref> Systolic blood pressure (SBP, A), heart rate (HR, B), left ventricular weight (C), and AngII plasma concentration (D) in CD-fed SD rats that were treated for 4 weeks with telmisartan (TEL; 8 mg•kg −1 •day −1 ) or telmisartan plus A779 (14 or 72 μg•kg −1 •day −1 , by osmotic minipumps).</s><s>Controls received vehicle and saline.</s><s>Means ± SEM, n = 11-12.</s><s>*P &lt; 0.05 versus vehicle + saline.</s><s>Figure <ref type="figure">S8</ref> Energy expenditure (EE; A-C) respiratory ratio (RER, D-F), locomotion (G-I) and energy intake (K-M) during indirect calorimetry measurements.</s><s>Animals were housed for 3 days in calorimetry cages, but only the data of the 3rd day are depicted.</s><s>Mean values during light and dark periods were calculated for EE (B, C), RER (E, F) and locomotion (H, I), whereas total energy intake was depicted specifically considering light (L) and dark periods (M).</s><s>Means ± SEM, n = 12, *P &lt; 0.05 versus vehicle + saline.</s><s>Table <ref type="table">S1</ref> Nutrition composition of chocolate and cookie bars.</s><s>Table <ref type="table">S2</ref> mRNA levels of orexigenic (PPO, NPY, MCH, AgRP) and anorexigenic peptides (POMC, CART, corticotropinreleasing hormone, CRH) in hypothalami of Sprague-Dawley (SD) rats or transgenic rats (TG) overexpressing Ang(1-7) that received control diet or cafeteria diet (CD).</s><s>Table <ref type="table">S3</ref> mRNA levels of orexigenic (PPO, NPY, MCH, AgRP) and anorexigenic peptides (POMC, CART, CRH) in hypothalami of rats of CD-fed SD rats that were treated with telmisartan (8 mg•kg −1 •day −1 ) or telmisartan plus A779 (24 or 72 μg•kg −1 •day −1 ) while controls received vehicle + saline.</s><s>Appendix S1 Supplementary methodical information to OGTT, ITT, LTT, RNA isolation, cDNA synthesis and quantification of mRNA as well as supplementary discussion on hypothalamic expression of (an-)orexigenic peptides.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors</title>
		<author>
			<persName><forename type="first">Sph</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Benson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Faccenda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Pawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Sharman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Spedding</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="page" from="1459" to="1581" />
			<date type="published" when="2013">2013a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The Concise Guide to PHARMACOLOGY 2013/14: Enzymes</title>
		<author>
			<persName><forename type="first">Sph</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Benson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Faccenda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Pawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Sharman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Spedding</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="page" from="1797" to="1867" />
			<date type="published" when="2013">2013b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Bader</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pflugers Arch</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="79" to="85" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>and Mas: the other side of the coin</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Banks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Farrell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="E10" to="E15" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Impaired transport of leptin across the blood-brain barrier in obesity</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Banks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Dipalma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Farrell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1341" to="1345" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Triglycerides induce leptin resistance at the blood-brain barrier</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Banks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Coon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moinuddin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Shultz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nakaoke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="1253" to="1260" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Angiotensin-(1-7) blockade attenuates captopril-or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">F</forename><surname>Benter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Yousif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Al</forename><surname>Saleh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Raghupathy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chappell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Diz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Pharmacol</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="559" to="567" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Bindom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Hans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Boulares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lazartigues</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice</title>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="2540" to="2548" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Birkenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Shulman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="713" to="723" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Differential mechanisms of ang (1-7)-mediated vasodepressor effect in adult and aged candesartan-treated rats</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bosnyak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Widdop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Denton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Hypertens</title>
		<imprint>
			<date type="published" when="2012">2012. 2012. 192567</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism</title>
		<author>
			<persName><forename type="first">M</forename><surname>Brink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wellen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Delafontaine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="2509" to="2516" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cabassi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Coghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Govoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Barouhiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Speroni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cavazzini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="2888" to="2897" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Feeding and reward: perspectives from three rat models of binge eating</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Corwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Avena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Boggiano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Behav</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="87" to="97" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Minireview: glucocorticoids -food intake, abdominal obesity, and wealthy nations in</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Dallman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>La Fleur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Pecoraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Houshyar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Akana</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="2633" to="2638" />
			<date type="published" when="2004">2004. 2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Minimal intensity physical activity (standing and walking) of longer duration improves insulin action and plasma lipids more than shorter periods of moderate to vigorous exercise (cycling) in sedentary subjects when energy expenditure is comparable</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Duvivier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Schaper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Bremers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Van Crombrugge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Menheere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kars</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e55542</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Physiology and pathophysiology of the adipose tissue renin-angiotensin system</title>
		<author>
			<persName><forename type="first">S</forename><surname>Engeli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Negrel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Sharma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1270" to="1277" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Feltenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Andrade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paraiso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">O</forename><surname>Barros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Filho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Sinisterra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="324" to="330" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Ferrario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jessup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Gallagher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Averill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Brosnihan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Ann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="2189" to="2196" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Z</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Aylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Carey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Liu</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">1-7) recruits muscle microvasculature and enhances insulin&apos;s metabolic action via mas receptor</title>
		<author>
			<persName><surname>Angiotensin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1219" to="1227" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Angiotensin-(1-7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Giani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Gironacci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Munoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Turyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Dominici</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Heart Circ Physiol</title>
		<imprint>
			<biblScope unit="volume">293</biblScope>
			<biblScope unit="page" from="H1154" to="H1163" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Giani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Munoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Silberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hocht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Taira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">296</biblScope>
			<biblScope unit="page" from="E262" to="E271" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Giani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Burghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Veiras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tomat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Munoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="page" from="F1606" to="F1615" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Neuromodulatory role of angiotensin-(1-7) in the central nervous system</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Gironacci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Longo Carbajosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Cerrato</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Sci (Lond)</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="57" to="65" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Renal actions of angiotensin-(1-7): in vivo and in vitro studies</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Handa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Ferrario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Strandhoy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">270</biblScope>
			<biblScope unit="page" from="F141" to="F147" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-{delta}-dependent pathways</title>
		<author>
			<persName><forename type="first">H</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Feng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="869" to="879" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Igase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Strawn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Gallagher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Geary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Ferrario</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats</title>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Heart Circ Physiol</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="H1013" to="H1019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ishiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Gallagher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Averill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Tallant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Brosnihan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Ferrario</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="970" to="976" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kadoguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kinugawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Takada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fukushima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Furihata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Homma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Physiol</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="312" to="322" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Animal research: reporting in vivo experiments: the ARRIVE guidelines</title>
		<author>
			<persName><forename type="first">C</forename><surname>Kilkenny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Browne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Cuthill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Emerson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="1577" to="1579" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Angiotensin II stimulates sympathetic neurotransmission to adipose tissue</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>English</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bharadwaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Cassis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Rep</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">e00014</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">U</forename><surname>Kintscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bramlage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Paar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Thoenes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Unger</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients</title>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Diabetol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">12</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Sorensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Vrang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Wulff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="2249" to="2259" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">H</forename><surname>Lv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes</title>
		<author>
			<persName><surname>Angiotensin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Diabetol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="291" to="299" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Guidelines for reporting experiments involving animals: the ARRIVE guidelines</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Mcgrath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Drummond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Mclachlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kilkenny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Wainwright</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="1573" to="1576" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Overfeeding-induced obesity in spontaneously hypertensive rats: an animal model of the human metabolic syndrome</title>
		<author>
			<persName><forename type="first">A</forename><surname>Miesel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Thermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heidbreder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dominiak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Raasch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Nutr Metab</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="127" to="142" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Double blockade of angiotensin II (AT(1))-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats</title>
		<author>
			<persName><forename type="first">A</forename><surname>Miesel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Müller-Fielitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Jöhren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Raasch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="2721" to="2735" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure</title>
		<author>
			<persName><forename type="first">H</forename><surname>Müller-Fielitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Markert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wittmershaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pahlke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Jöhren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Raasch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Naunyn Schmiedebergs Arch Pharmacol</title>
		<imprint>
			<biblScope unit="volume">383</biblScope>
			<biblScope unit="page" from="373" to="384" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARgamma target gene regulation</title>
		<author>
			<persName><forename type="first">H</forename><surname>Müller-Fielitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Landolt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heidbreder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Werth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Jöhren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1103" to="1115" />
			<date type="published" when="2012">2012a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Blood pressure response to angiotensin II is enhanced in obese zucker rats and is attributed to an aldosterone-dependent mechanism</title>
		<author>
			<persName><forename type="first">H</forename><surname>Müller-Fielitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Jöhren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Stellmacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schwaninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Raasch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page" from="2417" to="2429" />
			<date type="published" when="2012">2012b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Chronic blockade of angiotensin AT(1) receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats</title>
		<author>
			<persName><forename type="first">H</forename><surname>Müller-Fielitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hübel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mildner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Barkhausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Raasch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page" from="746" to="760" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats</title>
		<author>
			<persName><forename type="first">H</forename><surname>Müller-Fielitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Geissler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Werner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Piehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Raasch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="857" to="868" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Captopril intake decreases body weight gain via angiotensin-(1-7)</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">B</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="79" to="85" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Pawson</surname></persName>
			<affiliation>
				<orgName type="collaboration">NC-IUPHAR.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Sharman</surname></persName>
			<affiliation>
				<orgName type="collaboration">NC-IUPHAR.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Benson</surname></persName>
			<affiliation>
				<orgName type="collaboration">NC-IUPHAR.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Faccenda</surname></persName>
			<affiliation>
				<orgName type="collaboration">NC-IUPHAR.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Alexander</surname></persName>
			<affiliation>
				<orgName type="collaboration">NC-IUPHAR.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">P</forename><surname>Buneman</surname></persName>
			<affiliation>
				<orgName type="collaboration">NC-IUPHAR.</orgName>
			</affiliation>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucl Acids Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="D1098" to="D1106" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">N</forename><surname>Pecoraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Reyes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhargava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Dallman</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress</title>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="3754" to="3762" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Hypothalamic inflammation and the central nervous system control of energy homeostasis</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Pimentel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ganeshan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Carvalheira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<biblScope unit="volume">397</biblScope>
			<biblScope unit="page" from="15" to="22" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Pinheiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Kitten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Da Silveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Santos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="1184" to="1193" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle</title>
		<author>
			<persName><forename type="first">M</forename><surname>Prasannarong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Henriksen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">426</biblScope>
			<biblScope unit="page" from="369" to="373" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?</title>
		<author>
			<persName><forename type="first">W</forename><surname>Raasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bartels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rutten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dominiak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="2495" to="2504" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR</title>
		<author>
			<persName><forename type="first">W</forename><surname>Raasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Jöhren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gieselberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dominiak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="611" to="618" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">X</forename><surname>Rong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ebihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Naowaboot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kusakabe</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice</title>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="1727" to="1731" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Angiotensin II and 1-7 during aging in metabolic syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Rubio-Ruiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Valle-Mondragon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Castrejon-Tellez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Carreon-Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Diaz-Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Guarner-Lans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="101" to="108" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Angiotensin-(1-7)</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Santos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1138" to="1147" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Nadu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Braga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>De Almeida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Campagnole-Santos</forename><surname>Mj</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Genomics</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="292" to="299" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Verano-Braga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bader</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Angiotensin-(1-7) and Mas: new players of the renin angiotensin system</title>
	</analytic>
	<monogr>
		<title level="j">Angiotensin-converting enzyme</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="R1" to="R17" />
		</imprint>
	</monogr>
	<note>J Endocrinol</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Mario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Porto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Alvarez-Leite</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="340" to="347" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<monogr>
		<title level="m" type="main">Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Braga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Mario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Porto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Rodrigues-Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Murari</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010">2010</date>
			<biblScope unit="page" from="1" to="7" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="953" to="961" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Increased circulating angiotensin-(1-7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Guimaraes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>De Paula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Campagnole-Santos</forename><surname>Mj</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Regul Pept</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="64" to="70" />
			<date type="published" when="2012">2012b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Oral Angiotensin-(1-7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-kappaB in rats fed with high-fat diet</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Andrade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Sinisterra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Sousa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Feltenberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="47" to="52" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Giani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Burghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Miquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Qadri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Braga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Med (Berl)</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="255" to="265" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Schupp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Clemenz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gineste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Witt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Janke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Helleboid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="3442" to="3452" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Mas receptor deficiency is associated with worsening of lipid profile and severe hepatic steatosis in ApoE-knockout mice</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Aguilar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Alvarez-Leite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Arantes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bader</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="R1323" to="R1330" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway</title>
		<author>
			<persName><forename type="first">T</forename><surname>Skurk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Van Harmelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Blum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hauner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obes Res</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="969" to="973" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Mitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rosenthal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Delafontaine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="451" to="458" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Eckhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gagen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Laurent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1863" to="1871" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">In vivo characterization of the angiotensin-(1-7)-induced dopamine and gamma-aminobutyric acid release in the striatum of the rat</title>
		<author>
			<persName><forename type="first">B</forename><surname>Stragier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hristova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sarre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ebinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Michotte</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Neurosci</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="658" to="664" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Tabony</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sukhanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Delafontaine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Skelet Muscle</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">20</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Fatty acid metabolism, energy expenditure and insulin resistance in muscle</title>
		<author>
			<persName><forename type="first">N</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Cooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Kraegen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Bruce</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">220</biblScope>
			<biblScope unit="page" from="T61" to="T79" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Vazquez-Medina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Popovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Thorwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Viscarra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Sonanez-Organis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Heart Circ Physiol</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="H599" to="H607" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Converting enzyme determines plasma clearance of angiotensin-(1-7)</title>
		<author>
			<persName><forename type="first">K</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Iyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Chappell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ganten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Ferrario</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="496" to="502" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Semprun-Prieto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Wainford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sukhanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Kapusta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Delafontaine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1411" to="1420" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Ang(1-7) treatment attenuates beta-cell dysfunction by improving pancreatic microcirculation in a rat model of type 2 diabetes</title>
		<author>
			<persName><forename type="first">L</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Gong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol Invest</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="931" to="937" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Delafontaine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Garcia</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting</title>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="604" to="612" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ji</forename><forename type="middle">L</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">-7) protects against stress-induced gastric lesions in rats</title>
		<author>
			<persName><surname>Angiotensin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Pharmacol</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="467" to="476" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zorad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Dou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Benicky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hutanu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tybitanclova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">552</biblScope>
			<biblScope unit="page" from="112" to="122" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
